These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35107507)

  • 1. Pharmaceutical patent term extension and patent prosecution in Brazil (1997-2018).
    Mercadante E; Paranhos J
    Cad Saude Publica; 2022; 38(1):e00043021. PubMed ID: 35107507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?
    Mueller LL; Taketsuma Costa SM
    Expert Opin Ther Pat; 2014 Jan; 24(1):1-4. PubMed ID: 24206261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaching a milestone in pharmaceutical patenting in Brazil.
    Blasi GD
    Pharm Pat Anal; 2018 Nov; 7(6):229-233. PubMed ID: 30632452
    [No Abstract]   [Full Text] [Related]  

  • 4. [How much does the backlog on drug patents cost for health in Brazil?].
    Jannuzzi AHL; Vasconcellos AG
    Cad Saude Publica; 2017 Aug; 33(8):e00206516. PubMed ID: 28832788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The consequences of 'double examination' for pharmaceutical patent applications in Brazil.
    Salerno G
    Pharm Pat Anal; 2017 Mar; 6(2):49-51. PubMed ID: 28274178
    [No Abstract]   [Full Text] [Related]  

  • 6. Expedited pharma patenting in Brazil.
    Moreira P
    Pharm Pat Anal; 2019 Mar; 8(2):51-59. PubMed ID: 30887881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.
    Vasconcellos AG; Morel CM
    PLoS One; 2012; 7(10):e45569. PubMed ID: 23056208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Brazilian biotechnology patent activity from 1975 to 2010.
    Dias F; Delfim F; Drummond I; Carmo AO; Barroca TM; Horta CC; Kalapothakis E
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):145-59. PubMed ID: 22670606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patenting pharmaceuticals in China.
    Han W; Luo J
    Pharm Pat Anal; 2016 Jul; 5(4):249-59. PubMed ID: 27338759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patenting trends by Mexican pharmaceutical companies.
    Villafaña-Diaz L; Perez-Garcia JC; Barron-Villaverde D; Perez-Santos M
    Pharm Pat Anal; 2023 Nov; 12(6):275-286. PubMed ID: 38197381
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on Brazil's pharma patent landscape.
    Gosain R
    Pharm Pat Anal; 2016 Sep; 5(6):385-390. PubMed ID: 27804784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent term extensions: issues, challenges and implications for pharmaceuticals.
    Clark L; Beadle D
    Pharm Pat Anal; 2012 Sep; 1(4):427-35. PubMed ID: 24236881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The cost to the Brazilian Unified National Health System of the extension of drug patent terms].
    Paranhos J; Mercadante E; Hasenclever L
    Cad Saude Publica; 2020; 36(11):e00169719. PubMed ID: 33331592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonobviousness of pharmaceutical inventions: implications for patent prosecution and litigation.
    Dhulap S; Kulkarni M
    Pharm Pat Anal; 2019 Jul; 8(4):91-107. PubMed ID: 31414965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
    Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
    Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
    Xu Z; Chen W
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do patents tell us about microalgae in agriculture?
    Murata MM; Ito Morioka LR; Da Silva Marques JB; Bosso A; Suguimoto HH
    AMB Express; 2021 Nov; 11(1):154. PubMed ID: 34816320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in Brazil.
    Shadlen KC
    Polit Soc; 2011; 39(2):143-74. PubMed ID: 21913365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.